256 related articles for article (PubMed ID: 7530598)
41. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia.
Fishwild DM; Aberle S; Bernhard SL; Kung AH
Cancer Res; 1992 Jun; 52(11):3056-62. PubMed ID: 1375534
[TBL] [Abstract][Full Text] [Related]
42. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
[TBL] [Abstract][Full Text] [Related]
43. Differential effects of antibodies to Lyt-2 and L3T4 on cytolysis by cloned, Ia-restricted T cells expressing both proteins.
Jones B; Khavari PA; Conrad PJ; Janeway CA
J Immunol; 1987 Jul; 139(2):380-4. PubMed ID: 3110269
[TBL] [Abstract][Full Text] [Related]
44. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
Wen R; Blackman MA; Woodland DL
J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
[TBL] [Abstract][Full Text] [Related]
45. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
Surman S; Deckhut AM; Blackman MA; Woodland DL
J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
[TBL] [Abstract][Full Text] [Related]
46. Gamma delta T cell reactivity towards bacterial superantigens.
Rust CJ; Koning F
Semin Immunol; 1993 Feb; 5(1):41-6. PubMed ID: 8467094
[TBL] [Abstract][Full Text] [Related]
47. Localization of the immunologic activity in the superantigen Staphylococcal enterotoxin B using truncated recombinant fusion proteins.
Buelow R; O'Hehir RE; Schreifels R; Kummerehl TJ; Riley G; Lamb JR
J Immunol; 1992 Jan; 148(1):1-6. PubMed ID: 1530792
[TBL] [Abstract][Full Text] [Related]
48. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules.
Scholl PR; Diez A; Karr R; Sekaly RP; Trowsdale J; Geha RS
J Immunol; 1990 Jan; 144(1):226-30. PubMed ID: 2404064
[TBL] [Abstract][Full Text] [Related]
49. Functional epitope analysis of the human CD4 molecule. The MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless whether or not they recognize epitopes involved in the binding of MHC class II or HIV gp120.
Merkenschlager M; Buck D; Beverley PC; Sattentau QJ
J Immunol; 1990 Nov; 145(9):2839-45. PubMed ID: 1698863
[TBL] [Abstract][Full Text] [Related]
50. Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.
Dohlsten M; Abrahmsén L; Björk P; Lando PA; Hedlund G; Forsberg G; Brodin T; Gascoigne NR; Förberg C; Lind P
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8945-9. PubMed ID: 8090750
[TBL] [Abstract][Full Text] [Related]
51. Superantigen-mediated cellular cytotoxicity is dependent on antigen expression, but independent of the P-glycoprotein multidrug resistance phenotype.
Zehrer C; Beck J; Gekeler V; Ihle J; Holzer U; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
Br J Haematol; 1996 Dec; 95(3):452-6. PubMed ID: 8943883
[TBL] [Abstract][Full Text] [Related]
52. Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.
Fischer H; Dohlsten M; Lindvall M; Sjögren HO; Carlsson R
J Immunol; 1989 May; 142(9):3151-7. PubMed ID: 2785135
[TBL] [Abstract][Full Text] [Related]
53. Control of T cell responses to staphylococcal enterotoxins by stimulator cell MHC class II polymorphism.
Yagi JJ; Rath S; Janeway CA
J Immunol; 1991 Aug; 147(4):1398-405. PubMed ID: 1907996
[TBL] [Abstract][Full Text] [Related]
54. Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes.
Herrmann T; Accolla RS; MacDonald HR
Eur J Immunol; 1989 Nov; 19(11):2171-4. PubMed ID: 2599004
[TBL] [Abstract][Full Text] [Related]
55. Genetically engineered superantigens as tolerable antitumor agents.
Hansson J; Ohlsson L; Persson R; Andersson G; Ilbäck NG; Litton MJ; Kalland T; Dohlsten M
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2489-94. PubMed ID: 9122222
[TBL] [Abstract][Full Text] [Related]
56. Anti-class II antibodies in AIDS patients and AIDS-risk groups.
de la Barrera S; Fainboim L; Lugo S; Picchio GR; Muchinik GR; de Bracco MM
Immunology; 1987 Dec; 62(4):599-604. PubMed ID: 3501399
[TBL] [Abstract][Full Text] [Related]
57. Supplementary characteristics of anti-MHC class II monoclonal antibodies elicited by an ALL cell line: immunofluorescence cytofluorometry, C-dependent cytotoxicity, two-dimensional analysis of antigen.
Chorváth B; Duraj J; Sedlák J; Plesková I; Munozová H; Buc M
Neoplasma; 1987; 34(4):417-25. PubMed ID: 3309687
[TBL] [Abstract][Full Text] [Related]
58. A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells.
Hedlund G; Dohlsten M; Herrmann T; Buell G; Lando PA; Segrén S; Schrimsher J; MacDonald HR; Sjögren HO; Kalland T
J Immunol; 1991 Dec; 147(12):4082-5. PubMed ID: 1753087
[TBL] [Abstract][Full Text] [Related]
59. Locally superantigen-activated peritoneal cytolytic T lymphocytes belong to the CD8+ CD45RC- subset and lyse MHC class II+ tumor cells.
Hansson J; Ericsson PO; Dohlsten M; Sjögren HO; Kalland T; Hedlund G
Immunol Lett; 1992 Dec; 34(3):229-36. PubMed ID: 1487309
[TBL] [Abstract][Full Text] [Related]
60. Antibody-directed superantigen-mediated T-cell killing of myeloid leukaemic cell line cells.
Gidlöf C; Carlson B; Dohlsten M; Tötterman TH
Eur J Haematol; 1998 Apr; 60(4):233-9. PubMed ID: 9579876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]